Drugs and Devices

Fidaxomicin reduces C. diff recurrence

Compared to vancomycin, patients treated with fidaxomicin for Clostridium difficile infection were significantly less likely to have a recurrence. Read more here.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares